Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Life Sciences Alternative Funding
AddedFeb 15, 2024
UpdatedJun 28, 2026
Life Sciences Alternative Funding

Life Sciences Alternative Funding

Operating

Providing capital solutions for commercial-stage life sciences companies.

Location
Scarsdale, NY, US
Founded
2013
Firm
Compare
Portfolio
Employees
Website

Life Sciences Alternative Funding specializes in providing capital to commercial-stage life sciences companies. The firm focuses on debt financing and post-IPO debt rounds, typically investing around $15 million per deal. Their investment strategy targets companies that have already reached the commercial stage in the life sciences sector.

Notable portfolio companies include Harrow and VisionCare Ophthalmic Technologies. Life Sciences Alternative Funding's approach offers an alternative funding source for life sciences companies seeking capital beyond traditional equity investments, particularly those in later stages of development or post-IPO.

Life Sciences Alternative Funding - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments2
Current Portfolio Count1
Total Portfolio Exits1

Top Investment Stages

Debt Financing1 (50.0%)
Public1 (50.0%)

Stage Mix

Debt Financing 50%Public 50%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Harrow logo

Harrow

VisionCare Ophthalmic Technologies logo

VisionCare Ophthalmic Technologies

Similar Investment Firms

Mirae Asset Capital Life Science logo

Mirae Asset Capital Life Science

Bain Capital Life Sciences logo

Bain Capital Life Sciences

baincapital.com

Biomark Capital logo

Biomark Capital

Blackstone Life Sciences logo

Blackstone Life Sciences

blackstone.com

Nan Fung Life Sciences logo

Nan Fung Life Sciences

AI Life Sciences Investments logo

AI Life Sciences Investments

Alta Life Sciences logo

Alta Life Sciences

altals.com

Symbiotic Capital logo

Symbiotic Capital

symbcap.com

LifeSci Venture Partners logo

LifeSci Venture Partners

lifesciventure.com

Life Science Angels logo

Life Science Angels

Charter Life Sciences logo

Charter Life Sciences

Biospring Partners logo

Biospring Partners

biospring.com

Altitude Life Science Ventures logo

Altitude Life Science Ventures

altitudelsv.com

Perceptive Life Sciences logo

Perceptive Life Sciences

Hopen Life Science Ventures logo

Hopen Life Science Ventures

hopenls.com

Life Sciences Alternative Funding - Classification

Also Known As
  • Life Sciences Alternative Funding LLC
NAICS
  • 520000Finance and Insurance
SIC
  • 6000Depository Institutions